Phase Ib Trial of Metformin, Digoxin, Simvastatin in Patients With Advanced Pancreatic Cancer and Other Advanced Solid Tumors
The purpose of this phase Ib trial is to evaluate the safety and tolerability of metformin, digoxin and simvastatin in patients with pancreatic cancer and other advanced solid tumors.
Study ID: C3
Trial Phase: Phase I
Trial Sponsor: University of Toledo
Therapies Used in This Trial: C3 (Metformin, Digoxin, Simvastatin)